MicroRNA 503 is a non-coding RNA molecule that in humans is encoded by the MIR503 gene.
[1]
Function
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop.
Caporali A, Meloni M, Völlenkle C, Bonci D, Sala-Newby GB, Addis R, Spinetti G, Losa S, Masson R, Baker AH, Agami R, le Sage C, Condorelli G, Madeddu P, Martelli F, Emanueli C (2011). "Deregulation of microRNA-503 contributes to diabetes mellitus-induced impairment of endothelial function and reparative angiogenesis after limb ischemia". Circulation. 123 (3): 282–91. doi:10.1161/CIRCULATIONAHA.110.952325. PMID21220732.
Zhou J, Wang W (2011). "Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell". J Surg Oncol. 104 (3): 278–83. doi:10.1002/jso.21941. PMID21495032.
Roy P, Bhattacharya G, Lahiri A, Dasgupta UB, Banerjee D, Chandra S, Das M (2012). "hsa-miR-503 is downregulated in β thalassemia major". Acta Haematol. 128 (3): 187–9. doi:10.1159/000339492. PMID22890417.
Zhou B, Ma R, Si W, Li S, Xu Y, Tu X, Wang Q (2013). "MicroRNA-503 targets FGF2 and VEGFA and inhibits tumor angiogenesis and growth". Cancer Lett. 333 (2): 159–69. doi:10.1016/j.canlet.2013.01.028. PMID23352645.